International Assets Investment Management LLC Takes $1.05 Million Position in MetLife, Inc. $MET

Posted by Brenda Bartman on Jul 14th, 2026

International Assets Investment Management LLC purchased a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 14,885 shares of the financial services provider’s stock, valued at approximately $1,053,000.

Several other hedge funds have also recently bought and sold shares of the company. Activest Wealth Management raised its holdings in MetLife by 205.8% during the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 212 shares during the last quarter. Vermillion & White Wealth Management Group LLC grew its holdings in MetLife by 790.0% in the third quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 316 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in shares of MetLife in the fourth quarter valued at $30,000. Sound Income Strategies LLC increased its position in shares of MetLife by 58.9% in the fourth quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after buying an additional 142 shares in the last quarter. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new position in shares of MetLife during the 4th quarter worth $31,000. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife Price Performance

MetLife stock opened at $93.04 on Tuesday. MetLife, Inc. has a 12-month low of $67.33 and a 12-month high of $93.16. The stock has a market capitalization of $59.86 billion, a P/E ratio of 18.03, a P/E/G ratio of 0.69 and a beta of 0.78. The firm’s 50-day moving average is $84.69 and its two-hundred day moving average is $78.71. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.20 and a quick ratio of 0.20.

MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.15. The business had revenue of $14.18 billion during the quarter, compared to analyst estimates of $19.49 billion. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The company’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.96 earnings per share. Equities analysts predict that MetLife, Inc. will post 9.97 earnings per share for the current year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be paid a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, August 4th. MetLife’s payout ratio is presently 45.93%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Morgan Stanley boosted their price objective on shares of MetLife from $93.00 to $103.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Piper Sandler lifted their target price on shares of MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Bank of America reduced their price target on shares of MetLife from $103.00 to $99.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Evercore set a $96.00 price target on shares of MetLife in a research report on Thursday, April 9th. Finally, Mizuho raised their price objective on shares of MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $98.23.

View Our Latest Stock Analysis on MET

MetLife Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.